GLP-1 receptor agonist versus DPP-4 inhibitor and kidney and cardiovascular outcomes in clinical practice in type-2 diabetes
Yang Xu, Edouard L. Fu, Catherine M. Clase, Faizan Mazhar, Meg Jardine, Juan Jesús Carrero
Topics & Concepts
MedicineHazard ratioInternal medicineRenal functionMaceDipeptidyl peptidase-4Kidney diseaseType 2 diabetesSitagliptinMyocardial infarctionLixisenatideDiabetes mellitusEndocrinologyConfidence intervalPercutaneous coronary interventionLiraglutideDiabetes Treatment and ManagementChronic Kidney Disease and DiabetesPancreatic function and diabetes